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Purpose: To describe and test a new fully automatic
lesion detection system for breast DCE-MRI.
Materials and Methods: Studies were collected from two
institutions adopting different DCE-MRI sequences, one
with and the other one without fat-saturation. The detec-
tion pipeline consists of (i) breast segmentation, to iden-
tify breast size and location; (ii) registration, to correct for
patient movements; (iii) lesion detection, to extract con-
trast-enhanced regions using a new normalization tech-
nique based on the contrast-uptake of mammary vessels;
(iv) false positive (FP) reduction, to exclude contrast-
enhanced regions other than lesions. Detection rate
(number of system-detected malignant and benign lesions
over the total number of lesions) and sensitivity (system-
detected malignant lesions over the total number of ma-
lignant lesions) were assessed. The number of FPs was
also assessed.
Results: Forty-eight studies with 12 benign and 53 malig-
nant lesions were evaluated. Median lesion diameter was
6 mm (range, 5–15 mm) for benign and 26 mm (range, 5–
75 mm) for malignant lesions. Detection rate was 58/65
(89%; 95% confidence interval [CI] 79%–95%) and sensi-
tivity was 52/53 (98%; 95% CI 90%–99%). Mammary me-
dian FPs per breast was 4 (1st–3rd quartiles 3–7.25).
Conclusion: The system showed promising results on MR
datasets obtained from different scanners producing fat-
sat or non–fat-sat images with variable temporal and spa-
tial resolution and could potentially be used for early di-
agnosis and staging of breast cancer to reduce reading
time and to improve lesion detection. Further evaluation
is needed before it may be used in clinical practice.
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cer; DCE-MRI; automatic detection; fat-saturation
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BREAST CANCER IS the second most common malig-
nancy after lung cancer and the most common cancer
in women (1,2). Dynamic contrast-enhanced magnetic
resonance imaging (DCE-MRI) is a noninvasive imag-
ing technique increasingly used in breast cancer diag-
nosis as an adjunct to conventional imaging techni-
ques (3,4). DCE-MRI shows promise in detecting both
invasive and ductal carcinoma in situ cancers, gives
information on the biological aggressiveness of tumors
and may be used to evaluate response to neoadjuvant
chemotherapy (5–8).
However, DCE-MRI data analysis requires interpre-
tation of hundreds of images and is therefore time-
consuming (9). To reduce reporting time, lesions may
be isolated by segmentation. This image processing
procedure is preliminary to the extraction of quantita-
tive information on lesion morphology, kinetics, and
volume, and to distinguish viable from nonviable tis-
sue (10). Most segmentation methods are manual or
semi-automatic, have a degree of subjectivity, and
therefore may suffer from high inter- and intra-ob-
server variability (11–13). As it is not operator depend-
ent, a fully automatic lesion segmentation process
has the potential to reduce reading time and provide
more reproducible results. Unfortunately, few studies
have addressed automatic lesion detection and seg-
mentation techniques for breast DCE-MRI (14–16).
Furthermore, to our knowledge these methods have
been tested only on non–fat-saturated (fat-sat) con-
trast-enhanced images. Because enhancing lesions
may become isointense to adjacent fatty tissue after
contrast material injection, fat-saturation has been
introduced to enhance the contrast between lesion and
surrounding tissue and to overcome the limitations due
to subtraction artifacts (7). However, fat-sat sequences
introduce additional challenges for lesion segmentation,
such as artifacts from inhomogeneous signal saturation
and a lower contrast-to-noise-ratio between enhanced
lesions and surrounding parenchyma (17).
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The main aim of this study is to assess the per-
lesion sensitivity of a new, fully automatic algorithm
for breast lesion detection. The method has been devel-
oped to run on both fat-sat and non–fat-sat DCE-MRI
datasets obtained from different MR scanners.
MATERIALS AND METHODS
Patient Population and Study Design
The study consisted of a validation of a new algorithm
for the detection of breast lesions on DCE-MRI. Stud-
ies were collected from two institutions, each of them
using a different MRI equipment and a different proto-
col. The Local Ethical Committee approved the retro-
spective use of the database for scientific purposes
and waived the need for informed consent. The study
was conducted in accordance with national legislation
and the declaration of Helsinki.
The reference standard was surgery and histological
evaluation or follow-up in some benign lesions.
Enhanced areas smaller than 5 mm in diameter, the
so-called foci according to the definition of the Ameri-
can College of Radiology (ACR) Breast Imaging Report-
ing and Data System (BI-RADS) for breast MRI, were
not evaluated. In the majority of cases, these foci are
due to a focal proliferation of glandular tissue, known
as focal adenosis (7).
MRI Protocols
Group A included all studies acquired on a 1.5 Tesla
(T) scanner (Signa Excite HDx, General Electric
Healthcare, Milwakee, WI) using a eight-channel
breast radiofrequency coil and a fat-sat three-dimen-
sional (3D) axial fast spoiled gradient-echo sequence
(VIBRANTVR , General Electric) with the following tech-
nical parameters: repetition time/echo time (TR/TE) ¼
4.5/2.2 ms, flip angle 15, reconstructed matrix 512
 512, field of view 32 cm, slice thickness 2.6 mm,
pixel size 0.39 mm2. A total of seven scans were
acquired for each study: one baseline, 5 contrast-
enhanced frames with 50-s time resolution, and
one delayed frame acquired 7 minutes after contrast
injection. Gadopentetate dimeglumine (Gd-DPTA,
Magnevist, Bayer-Schering, Berlin, Germany) was
administered at a dose of 0.1 mmol/kg at 2 mL/s,
followed by 20 mL of saline solution at the same rate.
Group B comprised studies performed on a different
1.5T scanner (Sonata Maestro Class, Siemens, Erlan-
gen, Germany), using a dynamic 3D axial spoiled fast
low angle shot sequence using a four-element two-
channel coil, with the following technical parameters:
TR/TE ¼ 11/4.9 ms, flip angle 25, matrix 512 
512, field of view 384 mm, slice thickness 1.3 mm,
pixel size 0.56 mm2. Gd-BOPTA (MultiHance, Bracco,
Milan, Italy) was used as contrast agent, administer-
ing 0.1 mmol/kg at 2 mL/s, followed by 20 mL of
saline solution at the same rate. One baseline scan
was acquired before contrast injection, followed by 5
contrast enhanced frames taken 118 s apart. Fat-sat
sequences were not performed in group B patients.
Database Development
A training and a testing set were developed by ran-
domly selecting studies from the 2 groups. The train-
ing set was used to optimize the parameters of the
algorithms, whereas system performances were eval-
uated on the testing set. The characteristics of the
training set are detailed in Figure 1. Lesion greatest
diameter was measured manually by an experienced
radiologist with an electronic caliper on the axial
plane at its maximum extension. Median diameter
was 16 mm (range, 12–37 mm) for benign lesions and
19 mm (range 5–90 mm) for malignant lesions; 6 of
the 36 malignant lesions were sized 10 mm or less.
Image Processing
The detection pipeline (CADBREAST MRI, research
version, im3D) consists of four main processing steps:
breast segmentation, image registration, lesion detec-
tion and false positive (FP) reduction, none of which
Figure 1. Flow diagram showing main demographic, clinical and technical information of the study database. Fat-sat ¼ fat-
saturation scans. Non–fat-sat ¼ non–fat-saturated images. *DCIS ¼ Ductal Carcinoma In Situ.
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requires user interaction (see also Fig. 2). Breast seg-
mentation automatically identifies the breast and axil-
lary regions to reduce the computational burden and
prevent FPs due to enhancing structures (such as the
heart and extra-breast vessels). The contrast-enhanced
images are then registered to the unenhanced
image to correct for possible misalignments in the
dynamic sequence due to patient’s movement. The lesion
detection step consists in the extraction of suspicious
contrast enhanced areas and the FP reduction step
identifies and discards regions incorrectly extracted.
Breast Segmentation
This process includes the identification of the approxi-
mate size and location of each breast, and the breast
Figure 2. Main steps for breast segmentation and lesion detection for a non–fat-sat study. The unenhanced frame is shown
in (a); the mask resulting from breast segmentation is shown in (b). In (c) the maximum intensity projection (MIP) along the z
axis of the second enhanced subtracted frame is shown before registration: subtraction artifacts due to patient movement are
visible as spurious enhancing voxels (arrows). In (d) the same subtracted MIP after registration is shown: motion artifacts
have been removed (arrows). In (e) the results of automatic lesion detection are shown, while in (f) the segmentation results
after false positive reduction by means of morphological and kinetic criteria are illustrated.
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segmentation itself. A rough estimate of breast loca-
tion was obtained by identifying the most anterior
point reached by the breasts, which is defined as the
maximum point, and the minimum point which is
the deepest point within the concavity between the
breasts, as shown in Figure 3. These measures were
obtained following a rough segmentation of the
patient’s body. To separate the skin and internal
structures from external air, Otsu’s thresholding algo-
rithm (18) was applied to the unenhanced images.
This algorithm also allows for removing air from lungs
and other low intensity areas. Because of the high in-
tensity noise, the Otsu thresholding algorithm may
generate areas in the external air. To remove these
areas, the largest connected region, i.e., the breasts,
was selected by the algorithm and morphological
operations were then applied to fill holes (six dilations
and six erosions, both using a 5  5  5 kernel). The
algorithm then searches for the maximum point,
as previously defined, on the Otsu mask (Fig. 3c).
The central line, defined as the line running along the
concavity between the breasts, was computed by
exploiting image symmetry and by searching for the
skin voxel around the center of each slice (see Fig. 3).
If fat-sat is not used, the breasts can be easily iden-
tified based on the high signal intensity of fat tissue.
Similarly to the technique used by Twellmann et al
(16), a satisfactory segmentation can be obtained by
applying morphological operations such as hole filling
and dilation (6 steps with a 3  3  3 kernel) to the
thresholding results obtained by means of Otsu’s
method.
On the contrary, if fat-sat is used, intensity alone is
not sufficient to obtain a reliable segmentation.
Therefore, we have exploited an a priori knowledge of
the main anatomical structures in the field of view
using an atlas-based segmentation scheme. A simpli-
fied atlas was used in which the breasts, heart, chest
wall and lungs have been manually segmented and
color-coded.
Figure 3. Procedure for identification of the breast maximum point and central line. a: Unenhanced image. b: Result of Otsu’s
thresholding. The largest connected region comprises also the skin profile. c: Result of morphological operations (6 dilations
and 6 erosions, both with kernel 5  5  5). For each slice, each vertical line is scanned until the patient body is reached. The
position of the central line and the breast maximum point—shown by arrows—are identified. d: The mask obtained at step (c)
is also used to remove external air from the unenhanced image to suppress noise and artifacts in the external air.
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Because breast size and shape may vary consider-
ably across subjects, three different atlases were gen-
erated for large, medium and small breasts. The most
appropriate model was automatically selected for each
patient according to breast size, measured as the dis-
tance between the maximum point, and the minimum
point along the central line. The large model was cho-
sen for patients with estimated breast size larger than
10 cm, medium for patients with estimated breast
size between 7 and 10 cm, and small for patients with
estimated breast size smaller than 7 cm.
The patient body was identified by Otsu’s threshold-
ing method described above to mask noise present in
the external air (Fig. 3). The image was then down-
sampled at 1.25 mm  1.25 mm  2.6 mm resolution
to reduce the computational burden and registered to
the appropriate breast atlas.
Two examples of breasts segmentation results are
shown in Figure 4. The two methodologies yield
slightly different results in the axillary area, but this
is not compromising for the lesion detection. Axillae,
supraclavicular fossae, chest wall, and anterior medi-
astinum can be assessed by breast MRI (e.g. to search
for enlarged lymph nodes) but their evaluation could
be omitted as there is no evidence of its diagnostic
value (17).
Registration
This step is aimed at correcting possible misalignment
in the dynamic sequence due to patient motion. It
was performed by registering all the contrast-
enhanced images with reference to the unenhanced
sequence. Registration consists of two main steps.
First, the global misalignment was compensated by
using a translation and a rigid-body transformation.
Subsequently, local motion was corrected by a free-
form deformation model based on B-splines (19). In all
cases, mutual information was used as image similar-
ity measure, in particular by the method specified by
Mattes et al (20). Optimization was carried out by
means of a gradient descent optimizer for the rigid
registrations, and of the LBFGSB (Limited memory -
Broyden, Fletcher, Goldfarb, and Shannon - for Bound
constrained optimization) optimizer for the nonrigid
sub-step (21). Finally, the original contrast-enhanced
frames were warped to obtain the transformed
(aligned) contrast-enhanced frames by applying the
respective deformation field. In the warping, B-spline
interpolation was used to minimize the introduction of
sampling artifacts. An example of how registration
was able to compensate for motion artifacts is shown
in Figure 5.
Lesion Detection
Contrast enhancement of breast lesions shows large
physiologic variations, mostly depending on differen-
ces in vascular permeability (22,23) and other techni-
cal and physiological parameters, including type and
dose of contrast material (24,25). Differences may
depend on lesion histology, on the timing of imaging
or on inhomogeneities within the lesions, such as
those observed in necrotic areas or in fibrosis. To take
into account for the nonuniform uptake of contrast,
while reducing at the same time the computational
burden associated with the processing of all the con-
trast-enhanced registered frames, we used the sub-
tracted mean intensity projection image over time
(mIPT). Being the dynamic sequence a 4D image (x 
y  z  t), where t is time, the mIPT is the 3D image
(x  y  z) formed by averaging each voxel along the t
axis. Subtraction of the unenhanced frame was per-
formed to neglect the contribution of regions which do
not show contrast enhancement.
Different scanners, coils, acquisition modalities,
types and amounts of contrast agent injected,
patients’ physiology, and other external factors, result
in significant variations of image intensities among
images acquired in different hospitals, in different
patients, or even among different examinations from
the same patient (24,25). To compensate for these
effects, the subtracted mIPT was normalized by con-
trast enhancement of the mammary vessels.
Because the mammary vessels show maximum con-
trast enhancement in the early frames of the dynamic
sequence, they were automatically segmented on the
first subtracted contrast-enhanced frame.
Figure 4. a: Example of breast segmentation for a study acquired with fat-saturation. The breast mask extends further than
in non–fat-sat sequences, as defined by the breast atlas. b: Example of breast segmentation for a study acquired without fat-
saturation.
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A suitable ROI was automatically selected based on
the position of the central line by placing a rectangle of
a fixed size (50 mm  100 mm) in each slice, with the
exception of the upper 30% and lower 10% of the 3D
image slices that were not considered because the
mammary vessels are not usually visible. The mammary
vessels were then identified by applying to the ROI the
multiscale 3D Sato’s vessel enhancement filter, which is
based on the eigenvalues of the Hessian matrix (26,27).
The Sato’s vessel enhancement filter considers the
mutual magnitude of the eigenvalues as indicative of
the shape of the underlying object: isotropic struc-
tures are associated with eigenvalues which have a
similar nonzero magnitude, while vessels present one
negligible and two similar nonzero eigenvalues. Let
the eigenvalues of the Hessian matrix be l1, l2, l3
(with l1>l2>l3). On a given scale, vesselness is thus
defined as:
Vsðl1; lcÞ ¼
exp  l21
2ða1lcÞ2
 
if l1  0; lc 6¼ 0
exp  l21
2ða2lcÞ2
 
if l1 > 0; lc 6¼ 0
0 if lc ¼ 0
8><
>:
9>=
>;
; ½1
where lc ¼ min (l2, l3), a1 and a2 were set to 0.5. The
s footer in Vs indicates that the vesselness is com-
puted on a smoothed version of the image and is
therefore representative of the variations of image in-
tensity on the s spatial scale. As vessels in the breasts
could have different diameters, the vesselness is eval-
uated on a range of spatial scales, and the highest
response is selected for each voxel. Specifically, the
vesselness response is computed at 6 exponentially
distributed scales between the maximum and mini-
mum scales smin ¼ 0.5 and smax ¼ 1.0.
The most vessel-like voxels were selected by applying
a threshold equal to half the maximum vesselness value
observed in the ROI identified as described above. Fig-
ure 6 shows an example of mammary vessels.
The normalization factor was calculated as the mean
contrast enhancement of the mammary vessel voxels
in the first contrast-enhanced frame. After normalizing
the subtracted mean intensity projection, regions
showing contrast enhancement were extracted. Even if
the contrast-enhanced frames were normalized, we
have found that a fixed threshold was not suitable to
successfully segment lesions on all scans. A global
threshold TI was empirically determined as:
TI ¼ meanI þmaxI
3
; ½2
where meanI is the mean value of the normalized in-
tensity histogram of the breast and axillary region
and maxI is the highest intensity value observed in
the same region.
Because lesions are often connected to feeding ves-
sels, they are often segmented together. To prevent
lesion oversegmentation, which could reduce the diag-
nostic quality of the segmentation and limit the
performance of segmentation-based CAD applications,
voxels belonging to vessels were excluded from lesion
detection. For each voxel, the eigenvalues of the
covariance matrix were extracted, and the ratio
between the highest and medium eigenvalues was
used as a vesselness measure. Voxels with a ratio
larger than a fixed threshold Tv (where Tv ¼ 10) were
labeled as vessels and excluded from lesion detection.
Connected components were then extracted from the
resulting mask.
Figure 5. Comparison between subtracted images with and without registration. A slice from a non–fat-sat examination is
shown. a: Subtraction artifacts due to patient movement are visible along the breast profile (plain arrow), in the breast paren-
chyma (dot arrow), at lesion and vessel borders, as well as at the borders of fat lobules. These artifacts may introduce spuri-
ous enhancing voxels, thus increasing the number of false positive findings at segmentation. b: Subtraction artifacts are
dramatically reduced when elastic registration is used.
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False Positive Reduction
The regions showing contrast enhancement include
not only benign or malignant lesions, but also FPs
such as motion artifacts and noise. Moreover, not all
vessels are completely discarded during the lesion
detection step, and hence still contribute to the num-
ber of FPs. A few heuristic criteria were applied in our
algorithm to discard FPs. First, regions with a volume
of less than 20 mm3 were excluded. Taking into
account image resolution and possible lesion under-
segmentation, this roughly corresponded to a lesion of
5 mm in diameter, which is the cutoff between foci
and lesions (28).
Contrast enhancement kinetics can be classified as
curves I, II and III with an increasing probability of
malignancy (6%, 64%, and 87%, respectively) (29).
However, these curves are commonly referred to indi-
vidual voxels or to a set of few contiguous voxels
within a plane belonging to a single part of tissue with
uniform vascular characteristics, and thus homogene-
ous contrast enhancement, whereas the average in-
tensity curve calculated over an entire lesion (typically
without homogeneous vascular characteristics) is gen-
erally more similar to the average signal intensity
curves shown in Figure 7. Thus, our aim was to iden-
tify trends which are indicative of structures other
than benign and malignant lesions, such as noise,
artifacts or vessels.
Empirically, some simple kinetic features were
found to identify trends rather typical of vessels or
artifacts, as shown in Figure 7. For instance, artifacts
due to noise and patient motion are usually charac-
terized by high signal variations; hence, regions with
standard deviation greater than 150, or with a higher-
than-10% decrease or increase in signal intensity in
the last frame, with respect to the second-last frame,
were discarded. Furthermore, regions with mean
intensity decreasing from the first to the second
enhanced frame are discarded, as this pattern is
found in vessels but not in lesions.
Statistical Analysis
The results of the registration and breast segmenta-
tion steps were visually inspected by a radiologist
with more than 4 years of experience in breast MRI.
The radiologist labeled a finding as a true positive if
the lesion was confirmed at histology or at follow-up,
otherwise it was defined as a FP. Detection rate was
calculated as the number of true positives (both ma-
lignant and benign) over the total number of lesions
as defined at the reference standard, whereas sensi-
tivity was calculated as the number of malignant
lesions detected by the system over the total number
of malignant lesions. Lesions were grouped according
to size as follows: from 5 to 10 mm, 11 to 20 mm, and
larger than 20 mm (30) and detection rate and
Figure 6. a: First subtracted contrast-enhanced frame with the region where the mammary vessels are located in the
rectangle. b: Zoom of the region in the rectangle highlighted in (a). Arrows point mammary arteries that will be segmented by
the system.
Figure 7. Signal intensity curves calculated over an entire
connected component in the case of a lesion, a vessel and an
artifact.
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sensitivity were calculated for each group. Sensitivity
and detection rate values are presented with 95% con-
fidence intervals (CIs) using the Wilson method for sin-
gle proportions. Detection rate and sensitivity were
also separately calculated for fat-sat and non–fat-sat
exams, and the x2 test was used to assess differences
between the two subgroups. The detection rate of the
system for lesions satellite to index cancers detected
by radiologists for which a lesion-by-lesion pathological
analysis was not reported, was analyzed separately.
FP findings were defined by the radiologist as mam-
mary or extra-mammary findings, and characterized
either as vessels, image artifacts (i.e., skin, chemical
shift, patient movements, etc), lymph nodes, normal
gland or other findings (i.e., nipple, pectoral muscle,
heart, etc). The FP median, 1st and 3rd quartiles were
calculated for the entire testing set, for the fat-sat and
non–fat-sat subgroups. A two-sided Kruskal Wallis
test was applied to test for differences between the
medians for the total number of FP/patient.
A P level lower than 0.05 was considered statisti-
cally significant.
RESULTS
Algorithm performance was evaluated on a dataset of
48 DCE-MRI studies performed on women with suspi-
cion of breast cancer based on conventional imaging.
Relevant demographic, clinical and technical informa-
tion on the dataset is shown in the flow chart in Fig-
ure 1. The median of the largest diameter of benign
and malignant lesions was, respectively, 6 mm (range,
5–15 mm) and 26 mm (range, 5–75 mm). Overall,
there were 16 lesions sized 10 mm or less, 15 lesions
between 11 and 20 mm, and 34 lesions sized larger
than 20 mm.
The automatic algorithm detected 58 of the 65
lesions (89% detection rate; 95% CI 79–95%), includ-
ing 52 of the 53 malignant lesions (98% sensitivity;
95% CI 90–99%). Detection rate and sensitivity
according to lesion size are shown in Table 1.
In the fat-sat subgroup, 20 of the 25 lesions (80%
detection rate; 95% CI 61–91%) were detected, includ-
ing 19 of the 20 malignant lesions (95% sensitivity;
95% CI 76–99% ). In the non–fat-sat subgroup, 38 of
the 40 lesions (95% detection rate; 95% CI 84–99%)
were detected, including all 33 malignant lesions
(100% sensitivity; 95% CI 90–100%). Differences in
sensitivity and detection rate between the two groups
were not statistically significant (P ¼ 0.798 and P ¼
0.137 respectively).
A total of 7 lesions with an average size of 7 6
3 mm (mean 6 SD) were missed by the algorithm,
including 6 benign and 1 malignant nodules. Five of
the undetected lesions were in dataset A including: 2
fibroadenomas, 2 small enhancements with a negative
MRI follow-up of 5 and a 7 mm in size, respectively,
and a 12-mm invasive ductal carcinoma. Missed
lesions in dataset B were two 5 mm small enhance-
ments unchanged at MRI follow-up. Examples of
lesions detected and missed by the system are shown
in Figure 8.
In addition to malignant lesions histologically con-
firmed as a result of a lesion-by-lesion analysis in the
pathological report, 17 lesions satellite to malignant
index lesions, with a median diameter of 7 mm (range,
5–20 mm) were detected by two radiologists. Sixteen
of them (94%) were detected by the system.
Median mammary FPs per breast were 4 (1st–3rd
quartiles 3–7.25), while median extra-mammary FPs
per study were 2 (1st–3rd quartiles 1–5). Table 2
shows the distribution of findings according to the
type. For the fat-sat subgroup, median mammary FPs
per breast were 4 (1st–3rd quartiles 2–7.25); median
extra-mammary FPs per study were also 4 (1st–3rd
quartiles 3–6). In the non–fat-sat group, median
mammary FPs per breast were 4.5 (1st–3rd quartiles
3.5–7), while median extra-mammary FPs per study
were 1 (1st–3rd quartiles 1–2). No statistical signifi-
cant differences were detected between the two sub-
groups (P ¼ 0.72).
Average execution time was 5m48s for the non–fat-
sat group and 8m48s for the fat-sat group. Execution
time was measured on a computer equipped with a
CPU Intel Core i7 940 Quad Core @#2.93GHz archi-
tecture and 8 GBytes RAM.
DISCUSSION
This study demonstrated that the fully automatic
algorithm we developed for the detection of breast
lesions in DCE-MRI has a high performance and is
versatile as it can be used with different equipment
and acquisition modes. The system achieved a sensi-
tivity of 98%, with an acceptable number of FP find-
ings. Moreover, the good performances obtained in
detecting satellite lesions (16 of 17 were identified)
highlights the system’s potential in helping the detec-
tion of multifocal and multicentric breast cancers.
Fully automatic lesion detection has the potential of
reducing inter- and intra-observer variability and
reading time (11,13). However, few methods have
Table 1
Number of Lesions and Performance for Each Dimension Group
Lesions
Dimension (mm) # Malignant # Benign # Total
Detection Rate (Upper-Lower
Limits; 95% CI)
Sensitivity (Upper-Lower
Limits; 95% CI)
5–10 6 10 16 69% (44% – 86%) 100% (61% – 100%)
11–20 13 2 15 87% (62% – 96%) 92% (67% – 99%)
>20 34 0 34 100% (90% – 100%) 100% (90% – 100%)
Total 53 12 65 89% (79% – 95%) 98% (90% – 99%)
Lesions were grouped according to the National Cancer Institute. Detection rate and sensitivity were calculated with a 95% confidence
interval.
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been developed to date to detect breast lesions auto-
matically with DCE-MRI. Ertas et al developed an
automatic algorithm for the detection of breast lesions
based on cellular neural network segmentation and
3D template matching (14). They assessed the per-
formance of their system on a dataset of 39 lesions, of
which 19 were benign and 20 malignant. All MRI
studies were performed with non–fat-sat sequences
and they obtained a detection rate of 100% with less
than one FP per study. An automatic lesion detection
method based on support vector machine, proposed
by Twellmann et al also showed promising results,
yielding an area under the ROC curve of 0.98. How-
ever, the algorithm was tested on a limited dataset of
12 patients and only on non–fat-sat images (16). The
above mentioned methods cannot be applied to fat-sat
images as normalization is performed by dividing
each enhanced images by the unenhanced one. This
process yields very noisy images if fat-sat is applied,
as most of the breast signal is suppressed in the
unenhanced frame. Moreover, Ertas et al applied a
fixed threshold to extract suspicious areas and this
may limit the applicability to studies acquired with
different protocols.
Our algorithm takes advantage of the following
two innovative approaches. First, the normalization
technique we proposed is based on the contrast
enhancement of mammary vessels. Compared with
normalization with respect to the unenhanced image,
our approach gives stable results in the case of fat-sat
images, as the obtained normalization factor is related
to contrast agent administration. However, this
method requires that DCE-MRI is performed on the
axial plane, as the mammary vessels should be
included in the field of view with an adequate spatial
resolution. Second, we adopted the mIPT instead of
the commonly used MIPT (maximum intensity projec-
tion over time), because it is less sensitive to noise
and it produces more reliable segmentation.
There are some limitations to our method. First, the
detection was obtained using the mIPT and this pro-
cess could underestimate lesion size, as late enhanc-
ing voxels and voxels with a rapid washout can be
Figure 8. Examples of seg-
mentation results, superim-
posed on the normalized and
subtracted mean projection
over time. a: A 33-mm inva-
sive ductal carcinoma (fat-sat
image) correctly segmented;
(b) a 7-mm invasive ductal
carcinoma (fat-sat image) cor-
rectly segmented; (c) a 26-mm
invasive ductal carcinoma
(non–fat-sat image) correctly
segmented; (d) a 25-mm inva-
sive ductal carcinoma (fat-sat
image) correctly segmented;
here a 5-mm satellite lesion
(arrow) was missed by the
system.
Table 2
Classification of FP findings according to the type
FP findings
Type # %
vessels 267 54
artifacts* 113 23
gland 80 16
lymph nodes 2 0,4
other** 32 6
*i.e. chemical shift, skin, patient movements.
**i.e. nipple, pectoral muscle.
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attenuated when averaging over time. For applications
such as malignancy discrimination, a more accurate
identification of lesion boundary and morphology
could be useful, and a further refinement of the lesion
segmentation may become necessary. However, using
the MIPT also has limitations. It affects the number of
FPs negatively, as it is very sensitive to artifacts and
noise, and may lead to overestimation of lesion size
due to the ‘‘blooming sign’’ effect (31–33). Second, our
system has a higher number of FP findings if com-
pared with other academic software and to commer-
cially available solutions (34). Most of our FPs are ves-
sels, mainly tortuous vessels or bifurcations with low
vesselness values. Detection of bifurcations is a
known topological problem for vessel identification
and tracking (35,36). Reduction of the number of FPs
can conceivably be obtained by introducing a classifi-
cation stage dedicated to the recognition of vessels,
and more specifically of bifurcations. Improving the
accuracy of breast segmentation may also help reduce
the number of FP findings. FP reduction is achieved by
a set of simple heuristics criteria based on knowledge
of the morphological and kinetics properties of FPs. A
more efficient classifier could improve the system’s FP
rate. Finally, although the performances of our method
are promising, we must point out that the objective of
this study was solely lesion detection. Discrimination
between malignant and benign lesions should be
tackled in a future study, adding to our pipeline a clas-
sification step using morphological and kinetic fea-
tures. All lesions included in this dataset were mass-
like enhancements, but the performance on non–
mass-like enhancements should be likewise evaluated.
In conclusion, in this study we presented a new,
fully automatic lesion detection system for breast
DCE-MRI. The method was tested on MR datasets
obtained from different scanners, with a variable tem-
poral and spatial resolution and on both fat-sat and
non–fat-sat images, and has shown a high detection
rate and sensitivity, balanced by a reasonable low
number of FP findings. This type of system could
potentially be used for early diagnosis and staging of
breast cancer to reduce reading time and to improve
detection, especially of the smaller satellite nodules.
Further refinements are ongoing to improve vessel
detection, breast segmentation, and implement lesion
characterization.
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